NDC 82983-402 – Tacrolimus
Tacrolimus 5 mg/1 · Capsule · Oral
Product NDC82983-402
Product details
- Brand name
- Tacrolimus
- Generic name
- Tacrolimus
- Labeler
- Ajenat Pharmaceuticals LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA206651
- Marketed since
- January 31, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Calcineurin Inhibitor Immunosuppressant
Active ingredients
- Tacrolimus 5 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 82983-402-10 | 100 CAPSULE in 1 BOTTLE (82983-402-10) | Jan 31, 2023 |
Other Tacrolimus products
- 50090-5596 Tacrolimus 1 mg/1 · Capsule · A-S Medication Solutions
- 50090-5581 Tacrolimus 1 mg/1 · Capsule · A-S Medication Solutions
- 16729-041 Tacrolimus .5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-043 Tacrolimus 5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-042 Tacrolimus 1 mg/1 · Capsule · Accord Healthcare Inc.
- 82983-401 Tacrolimus 1 mg/1 · Capsule · Ajenat Pharmaceuticals LLC
- 82983-400 Tacrolimus .5 mg/1 · Capsule · Ajenat Pharmaceuticals LLC
- 68084-449 Tacrolimus .5 mg/1 · Capsule · American Health Packaging
- 68084-451 Tacrolimus 5 mg/1 · Capsule · American Health Packaging
- 68084-450 Tacrolimus 1 mg/1 · Capsule · American Health Packaging
- 43353-317 Tacrolimus 1 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 67877-278 Tacrolimus .5 mg/1 · Capsule · Ascend Laboratories, LLC